Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
120,494,078
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
82,817
-
Shares change
-
+82,817
-
Total reported value, excl. options
-
$54,460
-
Value change
-
+$54,460
-
Number of buys
-
1
-
Price
-
$0.6576
Institutional Holders of Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value (IKT) as of Q1 2023
As of 31 Mar 2023 Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value (IKT) had 1 institutional shareholder that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 82,817 shares of stock of the company.
Largest 1 holders included HAMILTON LANE ADVISORS LLC.
This table shows 1 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.